{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-025435","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.255562+00:00","generated_at":"2026-06-01T00:58:26.762423+00:00","sec_items":["3.03","5.03","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Daré Bioscience announces 1-for-12 reverse stock split effective July 1, 2024 to regain Nasdaq compliance","bullets":["1-for-12 reverse stock split effective July 1, 2024; shares reduce from ~101.1M to ~8.4M.","Purpose: regain compliance with Nasdaq $1.00 minimum bid price requirement.","Stockholder authorization obtained at June 5, 2024 annual meeting; Board set ratio at 1-for-12.","No fractional shares issued; fractional interests rounded up to next whole share after aggregation.","New CUSIP 23666P200; stock continues trading as DARE on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-025435","json":"https://secwatch.observer/filing/0001493152-24-025435.json","markdown":"https://secwatch.observer/filing/0001493152-24-025435.md","text":"https://secwatch.observer/filing/0001493152-24-025435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224025435/0001493152-24-025435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224025435/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:58:26.762423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}